# SNDL Inc. (SNDL) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Pharmaceuticals. Price $1.44, market value $357 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). SNDL Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **PEG: 0.57**. A PEG of 0.57 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 0.5×**. Each dollar of revenue is priced at 0.5×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 0.5×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **Free-cash-flow yield: 10.3%**. Free cash flow equals 10.3% of the market value. Above 5% is generally attractive.

## Profitability
- **Gross margin: 26.2%**. SNDL Inc. keeps 26.2% of revenue after the direct cost of what it sells.
- **Operating margin: -1.7%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -1.7%**. The company reported a net loss over the last twelve months.
- **Return on equity: -1.4%**. Return on equity is negative because earnings are negative.
- **Return on assets: -1.6%**. Each dollar of assets produces -1.6% of profit.

## Growth
- **Revenue growth (1 yr): 2.8%** (3-yr 9.9%/yr, 5-yr 73.1%/yr). Revenue grew 2.8% over the last year, against 73.1% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 83.3%**. Earnings per share rose 83.3%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Current ratio: 4.88** (quick 4.88). Current assets cover the next year's liabilities 4.88 times.
- **Altman Z-score: 3.08**. A Z-score of 3.08 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. SNDL Inc. does not currently pay a dividend, but it returned 6.8% of its market value through buybacks over the last year.

## Price and momentum
- **Total return (1 yr): -41.2%** (YTD -13.6%, 3-mo 1.1%). The shares are down 41.2% over twelve months including dividends.
- **From 52-week high: -50.3%** (23.2% above the low). Trading 50% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 66**. An RSI of 66 is neutral.
- **Beta (1 yr): 0.97** (volatility 59%). Beta of 0.97 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=SNDL · Page: https://foliofundamentals.com/stocks/sndl

Not investment advice.